Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 54

Results For "NDA"

5154 News Found

Astellas & Pfizer win FDA priority review for bladder cancer treatment expansion
News | April 22, 2026

Astellas & Pfizer win FDA priority review for bladder cancer treatment expansion

A decision is expected by August 17, 2026 under the Prescription Drug User Fee Act timeline


Leinco and CellCarta team up to power next-gen proteomics for cancer and targeted therapies
R&D | April 22, 2026

Leinco and CellCarta team up to power next-gen proteomics for cancer and targeted therapies

Together, the companies aim to deliver an integrated toolkit for biomarker discovery and clinical research


Experts discuss ways to strengthen adolescent mental health through ANUMATI 2.0
Public Health | April 22, 2026

Experts discuss ways to strengthen adolescent mental health through ANUMATI 2.0

Policy symposium in Hyderabad focuses on life skills education and community?driven solutions


Blueneem Medical Devices  appoints Manoj Tumkur Venkatachala as Chief Product Officer
People | April 22, 2026

Blueneem Medical Devices appoints Manoj Tumkur Venkatachala as Chief Product Officer

Manoj has over two decades of experience in healthcare operations and biomedical engineering


Centre of Excellence by Terumo India, AIG Hospitals to bridge IR skill gaps and reduce procedural risks
Hospitals | April 22, 2026

Centre of Excellence by Terumo India, AIG Hospitals to bridge IR skill gaps and reduce procedural risks

The programme integrates simulation-based training, expert-led sessions, and case-based discussions


Former VP M. Venkaiah Naidu praises Wadi Surgicals infrastructure in AMTZ, Visakhapatnam
Medical Device | April 22, 2026

Former VP M. Venkaiah Naidu praises Wadi Surgicals infrastructure in AMTZ, Visakhapatnam

The plant is currently scaling towards a production capacity of nearly 3 million gloves per day


ENSPRYNG cuts MOGAD relapse risk by 68% in landmark Phase III trial: Roche
Clinical Trials | April 22, 2026

ENSPRYNG cuts MOGAD relapse risk by 68% in landmark Phase III trial: Roche

The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents


Ultomiris shows strong interim results in Phase III IgA nephropathy trial
Clinical Trials | April 22, 2026

Ultomiris shows strong interim results in Phase III IgA nephropathy trial

IgAN is a rare, progressive kidney disease driven by abnormal IgA immune complexes that deposit in the kidneys


Freudenberg Medical launches ISO Class 5 cleanroom, 'CleanAssure'
Biopharma | April 21, 2026

Freudenberg Medical launches ISO Class 5 cleanroom, 'CleanAssure'

The cleanroom operates under stringent ISO Class 5 conditions, using ultrapure water and air systems


India Autism Center highlights inclusive residential care at ALFOC Conclave 2026
Healthcare | April 21, 2026

India Autism Center highlights inclusive residential care at ALFOC Conclave 2026

The conclave brought together key stakeholders from across the assisted living ecosystem